Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.425EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.425ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.425ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.144EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
CH.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CH.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CH.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CH.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CH.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EF.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EF.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
EF.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EF.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EF.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EF.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EF.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BR.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BR.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BR.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BR.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BR.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BR.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BR.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BR.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.2.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.2.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.2.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.1.2.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.2.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CP.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CP.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CP.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CP.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CP.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used